The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Context Despite increasing interest in advance care planning (ACP) and previous ACP
descriptions, a consensus definition does not yet exist to guide clinical, research, and policy …

Shared decision making for advanced heart failure has become both more challenging and
more crucial as duration of disease and treatment options have increased. High-quality …

Context Little is known about the effects of low health literacy among patients with heart failure,
a condition that requires self-management and frequent interactions with the health care …

Background Establishing the effectiveness of patient decision aids (PtDA) requires evidence
that PtDAs improve the quality of the decision-making process and the quality of the choice …

Objective. There is inadequate evidence of long-term benefit and growing evidence of the
risks of chronic opioid therapy (COT). Opioid dose reduction, or opioid tapering, may reduce …

Background— Conveying the complex trade-offs of continuous-flow left ventricular assist
devices is challenging and made more difficult by absence of an evidence summary for the full …

… These were sent to coauthors Daniel D. Matlock, Larry A. Allen, Allison Kempe, and …
statins, cancer, and HPV vaccine—were evaluated a final time by Allison Kempe, Daniel D. …

Background: Major gaps exist in the routine initiation and dose up-titration of guideline-directed
medical therapies (GDMT) for patients with heart failure with reduced ejection fraction. …

Frailty is the aggregation of subclinical physiological insults across many organ systems
resulting in a syndrome of heightened vulnerability in the face of stress. Measures of frailty are …